RO7497372

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7497372, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) [Phase 1]

See pricing